Inhibitory checkpoint molecules, such as CTLA-4, programmed cell death protein-1 (PD-1), and programmed cell death ligand 1 (PD-L1), can suppress anti-tumor immune responses in solid tumors [20]. This evidence concerns the gene CD274 and neoplasm.